Evaluation of left atrial characteristics and its impact on Prognosis in ESUS Patients: Insights from a cohort of AIS patients treated with mechanical thrombectomy or thrombolysis
M. Touma , C. Bergerot , T. Barret , J. Fort , C. Haddad , L. Mechtouff , H. Thibault
{"title":"Evaluation of left atrial characteristics and its impact on Prognosis in ESUS Patients: Insights from a cohort of AIS patients treated with mechanical thrombectomy or thrombolysis","authors":"M. Touma , C. Bergerot , T. Barret , J. Fort , C. Haddad , L. Mechtouff , H. Thibault","doi":"10.1016/j.acvd.2025.04.034","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Embolic strokes of undetermined source (ESUS) represent 1/6 ischemic stroke (IS) and have high recurrence rate. Their physiopathology is not fully understood. Studying ESUS patients and their left atrial (LA) characteristics may lead to more specific management strategies.</div></div><div><h3>Objectives</h3><div>To compare characteristics and prognosis of ESUS patients to those with atrial fibrillation (AF) and non-atrial causes, and to identify factors associated with MACE.</div></div><div><h3>Methods</h3><div>This study included patients with IS who underwent thrombectomy or thrombolysis and were followed for 1 year. Patients were classified by stroke etiology. The ESUS group was compared to AF (permanent and non-permanent) and a non-atrial causes group. Factors associated with MACE (overall mortality, stroke recurrence, and hospitalization for heart failure) were analyzed.</div></div><div><h3>Results</h3><div>The study included 337 patients: 64 with permanent and 84 with non-permanent AF, 106 with non-atrial causes, and 83 with ESUS. ESUS patients were older than the non-atrial group but younger than the AF groups. No difference was found in ECG LA myopathy criteria. Echocardiographic parameters showed the ESUS group was closer to the non-atrial group, with less LA remodeling, and significantly lower minimal and maximal indexed LA volumes and better strains in the three components than the AF groups. Reservoir strain in ESUS patients had a heterogeneous distribution (<span><span>Fig. 1</span></span>). The ESUS group had the worst prognosis. Factors associated with MACE were age, stroke history, peripheral artery disease, high blood pressure, inter-atrial blocks, and LV ejection fraction. LA strain tended to be associated with MACE.</div></div><div><h3>Conclusion</h3><div>In our cohort, the ESUS group presented less LA remodeling and dysfunction than the AF groups and were more similar to the non-atrial causes group. This could explain the lack of benefit from systematic anticoagulation treatments reported in ESUS groups. Further research is needed to better characterize this heterogeneous group.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 6","pages":"Pages S235-S236"},"PeriodicalIF":2.2000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213625002621","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Embolic strokes of undetermined source (ESUS) represent 1/6 ischemic stroke (IS) and have high recurrence rate. Their physiopathology is not fully understood. Studying ESUS patients and their left atrial (LA) characteristics may lead to more specific management strategies.
Objectives
To compare characteristics and prognosis of ESUS patients to those with atrial fibrillation (AF) and non-atrial causes, and to identify factors associated with MACE.
Methods
This study included patients with IS who underwent thrombectomy or thrombolysis and were followed for 1 year. Patients were classified by stroke etiology. The ESUS group was compared to AF (permanent and non-permanent) and a non-atrial causes group. Factors associated with MACE (overall mortality, stroke recurrence, and hospitalization for heart failure) were analyzed.
Results
The study included 337 patients: 64 with permanent and 84 with non-permanent AF, 106 with non-atrial causes, and 83 with ESUS. ESUS patients were older than the non-atrial group but younger than the AF groups. No difference was found in ECG LA myopathy criteria. Echocardiographic parameters showed the ESUS group was closer to the non-atrial group, with less LA remodeling, and significantly lower minimal and maximal indexed LA volumes and better strains in the three components than the AF groups. Reservoir strain in ESUS patients had a heterogeneous distribution (Fig. 1). The ESUS group had the worst prognosis. Factors associated with MACE were age, stroke history, peripheral artery disease, high blood pressure, inter-atrial blocks, and LV ejection fraction. LA strain tended to be associated with MACE.
Conclusion
In our cohort, the ESUS group presented less LA remodeling and dysfunction than the AF groups and were more similar to the non-atrial causes group. This could explain the lack of benefit from systematic anticoagulation treatments reported in ESUS groups. Further research is needed to better characterize this heterogeneous group.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.